Introduction
============

Osteoarthritis (OA) is a debilitating and multifactorial degenerative joint disease characterized by articular cartilage erosion and destruction, inflammation of the synovium, osteoproliferation of the joint edges, synovial hyperplasia and osteophyte formation at the joint margins ([@b1-etm-0-0-5788]). OA is associated with a loss of function of multiple diarthrodial joints in the body. Additionally, the related articular cartilage fibrosis, chaps, anabrosis and joint dislocation are major factors contributing to disability in the older population ([@b2-etm-0-0-5788],[@b3-etm-0-0-5788]). Although various studies have examined the molecular mechanisms of OA, alterations in the process of endogenous urinary metabolite formation during OA have not yet been published from the perspective of metabolomics ([@b4-etm-0-0-5788],[@b5-etm-0-0-5788]).

The discipline of metabolomics comprehensively examines changes in an organism\'s response to external processes under physiological and pathological conditions. This is achieved by observing how metabolite trajectories change over time when the biological system is stimulated in order to analyze differences in the metabolic fingerprint in different states ([@b6-etm-0-0-5788],[@b7-etm-0-0-5788]). Several different types of analytic platforms are able to achieve reasonable coverage of the metabolome, including nuclear magnetic resonance, Fourier transform infrared spectroscopy, high-performance liquid chromatography/mass spectrometry and gas chromatography-time of flight/mass spectrometry (GC-TOF/MS) ([@b8-etm-0-0-5788]). Among these, GC-TOF/MS is one of the most powerful and simple analytical platforms for achieving a comprehensive metabonomic analysis, with high sensitivity and reproducibility ([@b9-etm-0-0-5788]). Urine is commonly used as the analysis sample for metabolomics as GC-TOF/MS detection of urinary metabolomics has many advantages, such as being non-invasive, sensitive and rapid ([@b10-etm-0-0-5788]). Moreover, urinary metabonomic analysis is effective for monitoring the dynamic changes that occur during the progression of OA. Therefore, metabolomic methods 'import' the information from OA pathogenesis research to assess potential biomarkers that show disease-specific changes that may be related to the physiological state of biological systems, which can be applied widely ([@b11-etm-0-0-5788]).

The aim of the present study was to determine changes in the urinary metabolic profile in rats with knee osteoarthritis using GC-TOF/MS techniques to assess the perturbed metabolites to elucidate the potential metabonomic pathogenesis of OA.

Materials and methods
=====================

### Ethics statement

A total of 16 male Sprague-Dawley rats (200±20 g; 7 weeks old; specific pathogen-free grade) were purchased from the Experimental Animal Center of Anhui Medical University (Anhui, China). The experimental protocol was approved by the Committee on the Ethics of Animal Experiments of Anhui University of Chinese Medicine (Anhui, China; permit number: 2012AH-038-01). All surgery procedures were performed under sodium pentobarbital anesthesia (2 ml/kg) and all efforts were made to minimize suffering.

### Animal experimentation and sample collection

A total of 16 rats were allowed free access to food and water and were housed individually in a facility at 18--22°C with 40--60% humidity and a 12 h light/dark cycle. Following acclimatization for one week, rats were randomly divided into the control (n=8) and knee osteoarthritis (KOA) model (n=8) groups. KOA group rats were injected with 20 µl of 4% papain and 0.03 M L-cysteine into the right knee on days 1, 3 and 7 to establish the rat models of KOA. Following 14 days, urine samples were collected over 12 h from all rats and stored at −80°C until analysis.

### Drugs and reagents

Papain, L-cysteine and urease from *Canavalia ensiformis* (Jack bean) were purchased from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). L-2-chlorobenzene alanine (103616-89-3) was purchased from Hemboug Biotechnology, Co., Ltd., (Shanghai, China) and N,O-Bis(trimethylsilyl)trifluoroacetamide, including 1% v/v trimethylchlorosilane (TCMS) was purchased from REGIS Technologies, Inc., (Morton Grove, IL, USA).

### Instruments for analysis

Gas chromatography chromatograph (Agilent 7890A; Agilent Technologies, Inc., Santa Clara, CA, USA); mass spectrometer (Leco Chroma TOF Pegasus 4D; Leco, Co., St Joseph, MI, USA); and −80°C Ultra-Low Temperature Freezer (Thermo Fisher Scientific, Inc., Waltham, MA, USA).

### Histopathology

Rats were anesthetized intraperitoneally with sodium pentobarbital (2 ml/kg; intraperitoneal perfusion, Sigma-Aldrich; Merck KGaA). Blood was removed from the abdominal aorta to sacrifice the rats. Knee joints of each rat was fixed in 10% neutral formalin for 24 h at room temperature, then embedded in paraffin and cut into 4 µm sections. Paraffin-embedded liver sections were deparaffinized with xylene and rehydrated using an ethanol gradient (100-70% v/v). The sections were then stained with 0.5% (w/v) hematoxylin (5--10 min) and eosin (1--2 min) at room temperature for general observation. Cartilage specimens were fixed in 2.5% glutaraldehyde stationary liquid for 2 h at room temperature, dehydrated and embedded in an epoxy resin. Samples were then baked for 12 and 1 h in an oven at 45°C and 65°C, respectively. Ultra-thin (70 nm) sections were stained with toluidine blue for 30 min at room temperature. Finally, the sections were examined using a transmission electron microscope (JEM-1200X; JEOL Ltd., Tokyo, Japan).

### Sample preparation

A total of 100 µl from each sample was added to 1.5 ml Eppendorf tubes and combined with 10 µl of urease suspension (160 mg/ml in water). Samples were vortexed for 10 sec and subsequently incubated at 37°C for 1 h to decompose and remove excess urea, prior the addition of 0.35 ml of the extraction liquid (V~methanol~:V~chloroform~, 3:1). L-2-chlorophenylalanine (50 µl) from 0.2 mg/ml stock in dH~2~O was added to act as an internal standard. All samples were vortexed for a further 10 sec. Samples were centrifuged for 10 min at 4,200 × g at 4°C. Supernatant was transferred (\~0.35 ml) into 2-ml GC-TOF/MS glass vials. Extracts were dried in a vacuum concentrator without heating and 80 µl methoxymethyl amine salt (dissolved in pyridine; final concentration, 20 mg/ml) was added into dried metabolites, prior to incubation at 37°C for 2 h in an oven after mixing and sealing. Subsequently, 100 µl N,O-Bis(trimethylsilyl)trifluoroacetamide (containing 1% TCMS; v/v) was added into each sample before sealing and incubation at 70°C for 1 h. A total of 10 µl standard mixture, composed of fatty acid methyl esters (C8-C16, 1 mg/ml; C18-C30, 0.5 mg/ml in chloroform) was combined with the sample and cooled to room temperature. Samples were thoroughly mixed prior to GC-TOF/MS analysis.

### GC-TOF/MS analysis

An Agilent 7890 gas chromatograph system, coupled with a Pegasus high throughput time-of-flight mass spectrometer, was used for GC/TOF MS analysis. A DB-5MS capillary column, coated with 5% diphenyl cross-linked with 95% dimethyl polysiloxane (inner diameter, 30 m × 250 µm; film thickness, 0.25 µm; J&W Scientific Inc., Folsom, CA, USA) was used. A 1-µl aliquot of the analyte was injected in splitless mode. The carrier gas utilized was helium and the front inlet purge flow was 3 ml/min. There was agas flow rate of 20 ml/min through the column and the initial temperature was maintained at 50°C for 1 min, which was raised to 330°C at a rate of 10°C/min^−1^ and subsequently maintained at 330°C for 5 min. The temperatures of injection, transfer line and ion source were 280, 280 and 220°C, respectively, and the electron impact mode consisted of −70 eV of energy. Full-scan mode, with an m/z range of 85--600, a rate of 20 spectra per second and a solvent delay of 366 sec, allowed mass spectrometry data to be obtained.

### Statistical analysis

Raw peaks extraction, data baseline filtering and calibration of the baseline, peak alignment, deconvolution analysis, peak identification and integrated analysis were all performed using Chroma TOF4.3X software and Fiehn Rtx-5 database (both Laboratory Equipment Corp., Hayward, USA) ([@b12-etm-0-0-5788]). Principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA) and orthogonal partial least-squares discriminant analysis (OPLS-DA) were utilized to analyze the resulting data, using demonstration Simca Software (V13.0, Umetrics; Satorius Stedim Biotech, Umea, Sweden). Statistical analysis was performed using one-way analysis of variance and Student-Newman-Keul\'s testing, using SPSS 17.0 software (SPSS, Inc., Chicago, IL, USA). P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Histological changes

In the knee joints of the control group, H&E staining exhibited an orderly monolayer of synovial lining cells and cartilage, with an intact tidemark, normal cartilage cells, and no inflammatory cell infiltration or collagen fiber hyperplasia. In contrast, the joints in the KOA group indicated clear hyperplasia of the synovial lining cells, which was increased to three or four layers and gradual inflammatory cell infiltration and collagen fiber hyperplasia was observed.

Tissue ultrastructure in the control group showed that the cartilage cells were regularly arranged, with uniformly distributed central matrix fibers. Synovial cells exhibited a decreased number of rough endoplasmic reticulum and mitochondria in their cytoplasm, with microvilli protruding from the cell surface. In the KOA group, cartilage cells were irregularly shaped with a sparse matrix of plain fibers and synovial cells contained an increased number of rough endoplasmic reticulum in their cytoplasm. Furthermore, synovial cells exhibited mitochondrial degeneration with the appearance of some cavitation, as well as fewer microvilli protruding from the cell surface ([Fig. 1](#f1-etm-0-0-5788){ref-type="fig"}).

### Metabolite assignments with GC-TOF/MS spectroscopy

The total ion current (TIC) was expressed in response to all of the ions that contribute to the chromatogram, each peak of which represents a specific molecule ([@b13-etm-0-0-5788]). To investigate the differences between the metabolic spectra, the TIC of the metabolic spectra was analyzed. Chroma TOF4.3X software was used to correct the 1,144 data points by filling in blank entries, eliminating noise and subsequently centralizing to the interior labels. This resulted in the identification of 914 metabolic compounds with several distinct differences between the control and KOA spectra ([Fig. 2](#f2-etm-0-0-5788){ref-type="fig"}).

### PCA

PCA is a method to reduce the dimensionality of a dataset. Multiple variation variables are reduced into a few principal components that describe the structure of the original dataset, where the principal components of each sample represent the variations that best explain the entire sample dataset, which may be used to visually describe the changes in the metabolic patterns of the biological system in different physiological and pathological states ([@b14-etm-0-0-5788],[@b15-etm-0-0-5788]). In the present study, SIMCA-P^+^ software was used to recognize and analyze the multivariate patterns in the centralized data. PCA was used for mean-centered scaling to visualize the data and present the distribution of samples. Control and KOA groups were not completely separated due to disturbances by various factors; therefore, large differences were detected between the groups ([Fig. 3](#f3-etm-0-0-5788){ref-type="fig"}).

### PLS-DA

To further separate the groups, PLS-DA was used. PLS-DA provides a deeper analysis of the main metabolic characteristics of biological samples in different states and in the present study, it identified the main variables that distinguish the sample principal component space, presenting the potential biomarkers that are characteristic of the different biological states ([@b16-etm-0-0-5788]). A PLS-DA text model, using leave-one-out cross validation with R^2^ and Q^2^ that represent the predictable variables and predictability of the model, were used to judge the validity of the model. The data indicated that the control and KOA groups were entirely separate after applying the PLS-DA (R^2^=0.999; Q^2^=0.875), which revealed the stability, fit and predictivity of the mathematical model. Subsequently, the texting validity was assessed again by rearranging the experiment randomly through changing the sort order of the classification variable, Y, and randomly assigning Q^2^ up to 200 times. Values of R^2^=0.696 and Q^2^=−0.293 were obtained, which indicated that the model was reliable and not over-fit. The results of this analysis are shown in [Fig. 4](#f4-etm-0-0-5788){ref-type="fig"}.

### OPLS-DA

To further identify differences between the control and KOA groups, an orthogonal model was used and the first and second principal components based on OPLS-DA were analyzed ([@b17-etm-0-0-5788]). The two groups were separated completely after OPLS-DA ([Fig. 5](#f5-etm-0-0-5788){ref-type="fig"}), which suggested that several potential biomarkers in the urine were clearly altered in the KOA group when compared with the control group. Loading plots revealed the distribution of variables and identified differences in the compound present in the samples or groups based on those variables ([@b18-etm-0-0-5788]). Each dot in the loading plot represented a metabolite and the dots near the center indicated smaller differences between the groups than those shown by dots far away from the center. The red dots indicated the 23 potential biomarkers identified in the present experiment.

### Identification of endogenous metabolites

Significant differences between variables associated with their specificity as potential biomarkers were revealed, using variable importance projections of \>1 with Student\'s t-tests (P\<0.05; [Table I](#tI-etm-0-0-5788){ref-type="table"}). The retention time was used to determine the mass spectrogram for each metabolite and the Fiehn Rtx-5 database was used to authenticate the general structure of the identified potential biomarkers ([@b19-etm-0-0-5788]). Based on that analysis, multiple components were revealed as potential biomarkers, including, alanine, α-ketoglutarate, asparagine, maltose and glutamine, all of which were identified to be significantly altered in the KOA group when compared to the control group (P\<0.05; [Table I](#tI-etm-0-0-5788){ref-type="table"}).

### Network analysis

To investigate potential biomarkers that may be involved in metabolic pathways related to OA and to visualize the connections between the various pathways, physiological, biochemical and pathophysiological data were combined with the Human Metabolome Database (<http://www.hmdb.ca/about>) and observed. Together, these relevant literatures, which were domestically and internationally resourced, provided quantitative and metabolic information on the organism metabolites. The identified potential biomarkers for KOA were revealed to predominantly be connected with amino acid metabolism, energy metabolism, nucleic acid metabolism, fatty acid metabolism and vitamin B~6~ metabolism ([Fig. 6](#f6-etm-0-0-5788){ref-type="fig"}).

Discussion
==========

OA is a chronic and progressive joint disease that causes pathological characteristics, including articular cartilage erosion and destruction and synovial hyperplasia, particularly in the knee joint, which eventually results in the complete loss of joint function ([@b20-etm-0-0-5788]). Prior studies have indicated that injecting papain into the joint cavity is useful in constructing a KOA model, which identifies similar pathological alterations that are observed with OA in humans ([@b21-etm-0-0-5788],[@b22-etm-0-0-5788]). In addition, the KOA model may be established quickly, has a high success rate and is simple to perform, which explains why it is one of the classical models for investigating the pathogenesis of OA and drug screening ([@b23-etm-0-0-5788],[@b24-etm-0-0-5788]). The present study revealed that the synovial lining of the knee joint contained distinct collagen fiber hyperplasia, along with substantial inflammatory cell infiltration, which indicated the successful induction of KOA.

Genomics, proteomics and metabonomics together constitute 'systems biology', which is a discipline used to qualitatively and quantitatively analyze the small molecule metabolites of cells at specific times and under certain conditions, in order to describe the changes in the endogenous biological metabolites as a whole and their response to internal and external stimuli ([@b25-etm-0-0-5788],[@b26-etm-0-0-5788]). In the present study, GC-TOF/MS was used from the perspective of metabonomics to explore the pathogenesis of OA. A total of 23 potential biomarkers were identified, including alanine, α-ketoglutarate, asparagine, maltose and glutamine, all of which may be correlated to amino acid metabolism, energy metabolism, fatty acid metabolism, vitamin B~6~ metabolism or nucleic acid metabolism ([@b27-etm-0-0-5788]--[@b29-etm-0-0-5788]).

Glutamine is a non-essential amino acid that is found in abundance throughout the body and is involved in multiple metabolic processes. It is synthesized from glutamic acid and ammonia ([@b30-etm-0-0-5788]). N-carbamylglutamate is an azyl product of glutamate through carbamylation. Urocanic acid is a deamination (breakdown) product of histidine that is related to oxidative damage as a direct scavenger of reactive oxygen species (ROS) ([@b31-etm-0-0-5788]). 5-aminovaleric acid is a type of ornithine that participates in the urea cycle through amino acid catabiosis and by offering an amidogen to the urea cycle ([@b32-etm-0-0-5788]). Asparagine is generated from oxaloacetic acid by deamination, which then enters the tricarboxylic acid (TCA) cycle ([@b33-etm-0-0-5788]). Previous studies have revealed that hydroxyl radicals, ·OH, are important ROS in OA, which possess the fastest reactive chemical properties ([@b34-etm-0-0-5788]--[@b35-etm-0-0-5788]). Hydroxyl radicals may react with all types of amino acids, disrupting the ordered structure that produces amino acid chains of proteins and inducing collagen degradation and destruction of articular joint function in OA ([@b36-etm-0-0-5788]). In the present study, the contents of glutamine, N-carbamylglutamate, urocanic acid, 5-aminovaleric acid and asparagine were clearly decreased in the urine samples from the KOA group of rats, compared with that of the control group, which may be related to the generation of ·OH as this disrupts the structure of amino acids.

Alanine is one of the 20 different types of amino acids that constitute the proteins of the human body. Through the alanine-glucose cycle, alanine participates in the lactic acid-glucose cycle and subsequently enters the TCA cycle to regulate energy metabolism ([@b37-etm-0-0-5788]). In cases of chronic inflammation, such as joint inflammation in OA, lactic acid is a characteristic substance for detection that is also a pathogenic factor in the transformation of cells and development of autoantigenicity. When the lactic acid concentration becomes elevated an organism enters acidosis, thus further inducing the development of inflammation ([@b38-etm-0-0-5788]). In the present study, increased alanine content in the KOA group suggested an abnormal amino acid metabolism occurring in those animals.

Inflammatory factors in OA inhibit activation of insulin signaling, glycolysis and the pentose phosphate pathway, thereby increasing blood glucose levels ([@b39-etm-0-0-5788]). Phosphoenolpyruvate in the glycolysis pathway and erythrose 4-phosphate in the pentose phosphate pathway are synthesis products of shikimic acid that may be broken down into chorismic acid to generate 1,4-dihydroxy-naphthoic acid ([@b40-etm-0-0-5788]). N-acetyl-D-galactosamine, trehalose, gentiobiose and xylose provide energy for the organism through the pentose phosphate and glycolysis pathways ([@b41-etm-0-0-5788],[@b42-etm-0-0-5788]). Maltose is a primary disaccharide in the human diet, formed from two units of glucose joined with an alpha linkage. It is the second member of an important biochemical series of glucose chains ([@b43-etm-0-0-5788]). In the present study, the contents of shikimic acid, 1,4-dihydroxy-naphthoic acid, N-acetyl-D-galactosamine, trehalose, gentiobiose and xylose were decreased, while the maltose content was increased in the KOA group when compared with the control group, which may be related to the inhibition of the glycolysis and pentose phosphate pathways and increased blood glucose levels.

Tartronic acid and aminomalonic acid are two products of malonic acid, the structure of which is similar to succinic acid ([@b44-etm-0-0-5788]). Malonic acid is the archetypal example of a competitive inhibitor, which acts against succinate dehydrogenase (complex II) in the respiratory electron transport chain, thus mediating the TCA cycle ([@b45-etm-0-0-5788]). Oxidase activity was decreased in the present study during inflammatory damage caused by inflammatory factors and such incomplete oxidation may lead to lactic acid, pyruvic acid and α-ketoglutaric acid accumulation in the inflammation center. Furthermore, α-ketoglutaric acid may also be modified to succinyl-coenzyme A (succinyl CoA) through oxidation and decarboxylation. Succinyl-CoA produces further succinic acid and participates in the TCA cycle. Homogentisic acid is an intermediate of the metabolic breakdown of tyrosine and phenylalanine, which is found in the urine in cases of alkaptonuria ([@b46-etm-0-0-5788]). Mitochondrial dysfunction has been demonstrated in OA and the vast majority of enzymes that participate in TCA are located in the mitochondria of the cartilage cells, which may result in metabolic disturbance and abnormal metabolic intermediates from the TCA ([@b47-etm-0-0-5788]). The present study revealed that the content of α-ketoglutaric acid and homogentisic acid were increased and tartronic acid and aminomalonic acid were decreased in the KOA group, suggesting a possible association with abnormal energy metabolism.

2,8-hydroxyquinoline is a product of pyruvate metabolism that is further broken down into quinolinic acid. Quinolinic acid is an anti-inflammatory factor that exhibits catabolic, anti-microbial, anti-tumor, anti-fungal and anti-cancer effects ([@b48-etm-0-0-5788]). Oxygen depletion is one of the major features of OA, which prevents 2,8-hydroxyquinoline from generating quinolinic acid, thus aggravating OA-related inflammation. This interpretation is consistent with the present results, where the content of 2,8-hydroxyquinoline was decreased in the KOA group when compared with the control group.

Glycerol is an important component of triglycerides (fats and oils) and phospholipids, which are generated by D-(glycerol-1-phosphate). The glycerol component may be converted into glucose by the liver to provide energy for cellular metabolism. D-(glycerol-1-phosphate) is one of the phosphoric acid derivatives of glycerol and is generated from dihydroxyacetone phosphate by glycerophosphate dehydrogenase during glycolysis. Inflammatory factors inhibit the activation of insulin signaling and the glycolysis pathway in OA, resulting in decreases of D-(glycerol-1-phosphate) ([@b49-etm-0-0-5788],[@b50-etm-0-0-5788]). However, fat mobilization is accelerated, leading to the induction and activation of phospholipase C during OA, which functions as a secondary messenger. Glycerol formed from diglyceride also acts as a secondary messenger and levels of glycerol are increased during OA, further inducing the production of inflammatory factors ([@b51-etm-0-0-5788]). In the present study, the contents of diglycerol and D-(glycerol-1-phosphate) were increased in the KOA group when compared with the control, which may be associated with disorders of fatty acid metabolism.

4-pyridoxic acid is the catabolic product of vitamin B~6~. Together with vitamin B~6~, glycogen phosphorylase accelerates the transformation of glycogen into glucose ([@b52-etm-0-0-5788]). Inflammatory factors during OA inhibit the activation of insulin signaling, increasing blood glucose levels. In the present study, 4-pyridoxic acid content was increased in the KOA group when compared with the control group. Increases in 4-pyridoxic acid content may be related to disorders in vitamin B~6~ metabolism.

Inflammation during OA and ROS can lead to degraded bases resulting from nucleic acids attacked by the free radicals that induce collagen degradation, which may subsequently destroy joint function ([@b53-etm-0-0-5788]). Cytosine is a pyrimidine base that is a fundamental unit of nucleic acids and is involved in the synthesis and metabolism of nucleic acids. Compared with the control group, the cytosine content was decreased in the KOA group, which may be related to disorders of nucleic acid metabolism.

In conclusion, the metabonomic pathogenesis of OA may be related to disorders of amino acid metabolism, energy metabolism, fatty acid metabolism, vitamin B~6~ metabolism and nucleic acid metabolism.
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![Histological examination of knee cartilage on knee osteoarthritis rats using H&E staining (magnification, ×400) and electron microscopy (magnification, ×20,000). (A and B) H&E staining. (C and D) Electron microscope. A and C: control group; B and D: model group. H&E, hematoxylin and eosin.](etm-15-03-2777-g00){#f1-etm-0-0-5788}

![Gas chromatography-time of flight/mass spectrometry total ion current chromatograms (1144 peaks) of rat urine samples obtained from the control group and model groups. Each peak represents a specific molecule. NC, control group; OA, osteoarthritis group.](etm-15-03-2777-g01){#f2-etm-0-0-5788}

![Principal component analysis score plot of rat urine samples obtained from the control and model groups. Control and knee osteoarthritis groups are not completely separated due to disturbances by various factors, thus large differences are indicated between the groups. NC, control group; OA, osteoarthritis group.](etm-15-03-2777-g02){#f3-etm-0-0-5788}

![(A) Score plot of PLS-DA model was obtained from the control group and KOA model group and (B) two hundred permutations were performed, which were plotted according to the resulting R^2^ and Q^2^ values: R^2^=0.696 and Q^2^=−0.293. KOA, knee osteoarthritis; PLS-DA, partial least squares discriminant analysis; NC, control group; OA, osteoarthritis group.](etm-15-03-2777-g03){#f4-etm-0-0-5788}

![(A) Orthogonal projections to latent structures-discriminant analysis score plot of rat urine samples obtained from the control and knee osteoarthritis model groups. (B) Each dot in the loading plot represents a metabolic substance of the most influential variables, according to their respective contributions to the discrimination. Red dots indicated the potential biomarkers. OPLS-DA, orthogonal partial least-squares discriminant analysis; NC, control group; OA, osteoarthritis group.](etm-15-03-2777-g04){#f5-etm-0-0-5788}

![Pathway network analysis. Metabolites in the red frame depict those that are increased in the KOA model group when compared to the control group; metabolites in the green frame depict those that are decreased in the KOA model group when compared to the control group. Both denote the endogenous metabolites identified which are associated with various possible metabolic pathways. KOA, knee osteoarthritis; TCA, triglycerides; UTP, uridine-triphosphate; ATP, adenosine triphosphate; CTP, cytidine triphosphate; OAA, oxaloacetate; E4P, erythrose 4-phosphate; DMAP, N,N-Dimethylpyridin-4-amine; succinyl CoA, Succinyl-Coenzyme A; \*P\<0.05 vs. control, \*\*P\<0.01 vs. control.](etm-15-03-2777-g05){#f6-etm-0-0-5788}

###### 

Biomarkers and change trends of KOA rats in each group.

  No.   VarID   Possible compounds               RT         VIP      P-value^[a](#tfn2-etm-0-0-5788){ref-type="table-fn"}^
  ----- ------- -------------------------------- ---------- -------- -------------------------------------------------------
  1     83      Alanine                            7.9005   3.1979   0.0099
  2     317     Tartronic acid                   11.8798    2.8602   0.0061
  3     383     Aminomalonic acid                12.9363    1.3812   0.0435
  4     439     Cytosin                          13.7735    3.2025   0.0078
  5     467     α -ketoglutaric acid             14.2475    1.2320   0.0256
  6     504     Asparagine                       14.7184    1.1209   0.0340
  7     516     5-aminovaleric acid              14.8493    1.0065   0.0218
  8     535     Xylose                           15.1326    3.3137   0.0007
  9     581     Glutamine                        15.8341    1.2421   0.0094
  10    609     Diglycerol                       16.3407    2.1399   0.0181
  11    614     D-(glycerol 1-phosphate)         16.3322    3.0259   0.0054
  12    639     Shikimic acid                    16.7887    1.4643   0.0383
  13    657     Homogentisic acid                17.1321    3.1284   0.0038
  14    659     N-carbamylglutamate              17.1346    2.6190   0.0063
  15    668     2,8-dihydroxyquinoline           17.2756    1.5259   0.0256
  16    734     4-pyridoxic acid                 18.1958    2.3907   0.0072
  17    744     D-galacturonic acid              18.4139    3.3468   0.0001
  18    776     Urocanic acid                    18.9242    3.2128   0.0027
  19    806     N-acetyl-D-galactosamine         19.3819    2.6484   0.0021
  20    865     1,4-dihydroxy-2-naphthoic acid   20.4740    1.9413   0.0111
  21    1063    Trehalose                        24.8046    1.8507   0.0059
  22    1076    Maltose                          25.0642    2.6504   0.0002
  23    1091    Gentiobiose                      25.4649    1.0073   0.0052

Screening of 1,166 peaks corresponding to the number of substances in the serum after VarID was used to import the software.

Model group vs. control group. RT, retention time of the substance; KOA, knee osteoarthritis; VIP, variable importance projection.
